We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPathfinder Minerals Regulatory News (PFP)

  • This share is currently suspended. It was suspended at a price of 0.275

Share Price Information for Pathfinder Minerals (PFP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
PFP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update Re Issue of Equity

28 May 2020 15:16

RNS Number : 2655O
Pathfinder Minerals Plc
28 May 2020
 

28 May 2020

Pathfinder Minerals Plc

("Pathfinder" or the "Company")

 

Update Re Issue of Equity

 

Further to the Issue of Equity announcement released by the Company on 11 May 2020, Pathfinder has agreed, following discussions with its broker, to amend the terms of the placing and subscription to align pricing closer to the Company's current share price.

In aggregate, the same quantum of gross proceeds of £250,000 is still to be raised via a placing and subscription, which will now be for 38,461,538 new ordinary shares of 0.1p each in the Company ("Ordinary Shares"), reflecting an issue price of 0.65p per share (the "Fundraise"), being equal to the closing mid-market share price of the Company on 27 May 2020.

 

As previously announced, the net proceeds will provide the Company with additional working capital to pursue the recovery of an interest in Mining Concession 4623C, as well as for general working capital purposes. When added to the expected cash inflow from the convertible loan note instrument announced on 3 April 2020, the Board believes the Company should have sufficient funds on its current cost basis to continue operations into 2021.

 

Annual Broker Fees

 

As previously announced, the Company has appointed Novum Securities Limited ("Novum") as its broker. The Company has agreed with Novum to settle its annual broking fee in advance through the issuance of 3,076,923 new Ordinary Shares to Novum (the "Fee Shares").

 

Admission to trading on AIM

 

The Company will apply for the admission of the 38,461,538 new Ordinary Shares to be issued pursuant to the Fundraise (the "Fundraise Shares") and the 3,076,923 Fee Shares to trading on AIM and this is expected to take place on or around 3 June 2020 ("Admission"). 

 

Following Admission, the Company's issued share capital will consist of 360,223,831 Ordinary Shares with no Ordinary Shares held in treasury. Therefore, the above figure of 360,223,831 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Pathfinder under the FCA's Disclosure and Transparency Rules.

 

Richard Jennings, who, together with his related parties, Align Research and C. A. Jennings, currently holds a total of 9.1 percent of the Company's issued share capital, has committed to subscribe for 3,076,923 Fundraise Shares on the revised terms. Following Admission of the Fundraise Shares and the Fee Shares, Align Research and related parties - R. S. and C. A. Jennings, will have an enlarged shareholding of 32,076,923 Ordinary Shares, representing 8.9 percent of the then enlarged issued share capital of the Company. 

 

Issue of Warrants

 

Pursuant to the Fundraise, the Company has also issued to the recipients of the Fundraise Shares warrants to subscribe for one new Ordinary Share for every one Fundraise Share subscribed for, with an exercise price of 1.5p (the "Warrants"), 50 percent of which are proposed to be allotted and issued by the Company pursuant to the Fundraise by Admission, and 50 percent to be issued conditional upon the passing of the necessary resolutions by shareholders at the next General Meeting of the Company authorising their allotment (the "GM Approval"), exercisable for a period of two years from the date of the admission to trading on AIM of the Fundraise Shares.

 

In connection with the Fundraise, the Company has agreed to issue Novum warrants over 3,230,769 Ordinary Shares (previously 1,800,000 Ordinary Shares) on the same terms as above (the "Novum Warrants"). Warrants over a further 153,846 Ordinary Shares (previously 200,000 Ordinary Shares) will be issued to another corporate adviser in relation to the Fundraise (the "Other Adviser Warrants"). The issuance of the Novum Warrants and the Other Adviser Warrants will also be subject to GM Approval.

 

 

Dennis Edmonds, Chief Executive Officer of Pathfinder, commented:

 

"We are encouraged that all of the investors have maintained their commitment to the Fundraise, rebased to yesterday's closing share price. We continue to work towards a commercial resolution to the licence dispute."

 

Enquiries:

Pathfinder Minerals Plc

Dennis Edmonds, Chief Executive Officer

Tel. +44 (0)20 3440 7775

 

Strand Hanson Limited (Nominated & Financial Adviser)

James Spinney / Ritchie Balmer / Jack Botros

Tel. +44 (0)20 7409 3494

 

Vigo Communications (Public Relations)

Ben Simons / Simon Woods

Tel. +44 (0)20 7390 0234

Email. pathfinderminerals@vigocomms.com

 

Novum Securities Limited (Corporate Broker)

Colin Rowbury / Jon Belliss

Tel. +44 (0)20 7399 9400

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEFLFLSEEITFII
Date   Source Headline
22nd Oct 20207:00 amRNSHolding(s) in Company
19th Oct 202012:08 pmRNSWarrant Exercise, CLN Repayment and TVR
14th Oct 202011:28 amRNSIssue of Equity
7th Oct 202011:57 amRNSWarrant Exercise, CLN Repayment and TVR
11th Sep 202010:49 amRNSHolding(s) in Company
4th Sep 20202:39 pmRNSHolding(s) in Company
4th Sep 20202:36 pmRNSHolding(s) in Company
3rd Sep 20202:40 pmRNSWarrant Exercise, CLN Repayment and TVR
28th Aug 20201:23 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSDirector/PDMR Shareholding
4th Aug 202012:29 pmRNSResult of AGM
13th Jul 20207:00 amRNSNotice of AGM
3rd Jul 20207:00 amRNSDirectorate Change
30th Jun 20207:00 amRNSFinal Results
29th May 202011:05 amRNSSecond Price Monitoring Extn
29th May 202011:00 amRNSPrice Monitoring Extension
29th May 20207:00 amRNSFurther Update re Issue of Equity
28th May 20203:16 pmRNSUpdate Re Issue of Equity
27th May 20207:00 amRNSUpdate on Mozambique Court Proceedings
11th May 20202:45 pmRNSResult of GM / Issue of Equity
24th Apr 20207:00 amRNSNotice of General Meeting
17th Apr 20207:00 amRNSHolding(s) in Company
6th Apr 20207:00 amRNSAlign Research Updates Coverage on Pathfinder
3rd Apr 202011:37 amRNSFundraising
1st Apr 20207:00 amRNSCorporate Update
3rd Jan 202011:20 amRNSCorporate Update
24th Oct 201910:16 amRNSCorporate Update
27th Sep 20191:06 pmRNSHalf-year results
2nd Aug 20197:00 amRNSDirectorate Change
23rd Jul 20193:36 pmRNSResult of AGM
23rd Jul 20197:00 amRNSDirectorate Change
16th Jul 201912:08 pmRNSExercise of Warrants
9th Jul 20197:00 amRNSExercise of Warrants
4th Jul 20199:56 amRNSGrant of Share Options - Replacement
4th Jul 20197:00 amRNSGrant of Share Options
3rd Jul 201912:00 pmRNSExercise of Warrants & Issue of Fee Shares
28th Jun 201911:47 amRNSFinal Results
26th Jun 20197:00 amRNSHolding(s) in Company
25th Jun 20197:36 amRNSHolding(s) in Company
12th Jun 20193:24 pmRNSExercise of Warrants
7th Jun 20191:59 pmRNSExercise of Warrants & Total Voting Rights
6th Jun 20197:00 amRNSExercise of Warrants & Total Voting Rights
5th Jun 20193:02 pmRNSIssue of Equity & Total Voting Rights
3rd Jun 20197:01 amRNSCorporate Update & Directorate Change
3rd Jun 20197:00 amRNSExercise of Warrants
1st May 20191:06 pmRNSHolding(s) in Company
30th Apr 20191:51 pmRNSHolding(s) in Company
10th Apr 20193:49 pmRNSCorporate Update | Subscription & Issue of Equity
11th Feb 20197:00 amRNSCorporate Update
7th Nov 201811:57 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.